KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - OtherShares Repurchased
Ratios

Gilead Sciences (GILD) Shares Repurchased (2016 - 2025)

Gilead Sciences (GILD) has disclosed Shares Repurchased for 17 consecutive years, with $230.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Repurchased fell 34.29% year-over-year to $230.0 million, compared with a TTM value of $1.9 billion through Dec 2025, up 67.13%, and an annual FY2025 reading of $1.9 billion, up 67.13% over the prior year.
  • Shares Repurchased was $230.0 million for Q4 2025 at Gilead Sciences, down from $435.0 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $792.0 million in Q4 2022 and bottomed at $43.0 million in Q2 2021.
  • Average Shares Repurchased over 5 years is $300.7 million, with a median of $300.0 million recorded in 2023.
  • The sharpest move saw Shares Repurchased surged 1516.33% in 2022, then tumbled 81.06% in 2023.
  • Year by year, Shares Repurchased stood at $49.0 million in 2021, then soared by 1516.33% to $792.0 million in 2022, then crashed by 81.06% to $150.0 million in 2023, then surged by 133.33% to $350.0 million in 2024, then tumbled by 34.29% to $230.0 million in 2025.
  • Business Quant data shows Shares Repurchased for GILD at $230.0 million in Q4 2025, $435.0 million in Q3 2025, and $527.0 million in Q2 2025.